Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/fda-rejects-clovis-long-shot-bid-approval-rubraca
https://www.fiercepharma.com/pharma/bankruptcy-clovis-sells-remaining-assets-including-rubraca-70m
https://www.fiercepharma.com/pharma/ema-requests-more-data-fda-spots-potential-harm-clovis-limps-through-rubraca-apps-amid
https://www.biospace.com/article/embattled-clovis-oncology-files-for-chapter-11-sells-radioligand-therapeutic-to-novartis/
https://www.reuters.com/business/healthcare-pharmaceuticals/us-drugmaker-clovis-files-chapter-11-bankruptcy-2022-12-12/
https://www.ema.europa.eu/en/documents/overview/rubraca-epar-medicine-overview_en.pdf
https://www.fiercepharma.com/pharma/free-fall-clovis-defaults-loan-and-agrees-pull-another-indication-rubraca
https://www.fiercepharma.com/pharma/fda-tightens-noose-around-clovis-neck-demanding-rubraca-ovarian-cancer-restriction-after
https://www.reuters.com/business/healthcare-pharmaceuticals/clovis-oncology-says-could-file-bankruptcy-very-near-term-2022-11-09/